OR WAIT null SECS
September 13, 2019
Bora Pharmaceuticals has announced it has achieved success in the latest FDA general inspection of its Zhunan facility with zero 483 observations.
August 02, 2019
CMOs and CDMOs expanded their services and facilities in the summer of 2019.
To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.
Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.
July 16, 2019
An agreement with Sanofi gives Catalent access to commercial spray drying facility in Haverhill, UK.
June 20, 2019
The company has expanded its high-potency API capability at its Riverview, MI, facility to serve the growing antibody drug conjugates market.
June 17, 2019
Two additional production lines expand Lonza’s HPAPI capacity at Visp, Switzerland facility.
June 07, 2019
Tergus Pharma announced a partnership with Great Point Partners and construction of a new commercial manufacturing facility in North Carolina.
May 28, 2019
Expanded controlled substance capabilities enables Particle Sciences to develop and manufacture Schedule I–V drugs.
May 17, 2019
The company announced plans to construct a 1.3 million-ft2 integrated manufacturing center in Chengdu, China.
